Skip to content
Fencer Intel
medium 5.3

CVE-2024-11083 json

ProfilePress <= 4.15.18 - Unauthenticated Content Restriction Bypass to Sensitive Information Exposure

published last yr. modified 5mo ago also EUVD-2024-33738

cvss
5.3
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.4%
EPSS 0.4% chance of exploitation in 30 days, percentile 39%
public exploits
0
none known

Summary

The ProfilePress plugin for WordPress is vulnerable to Sensitive Information Exposure in all versions up to, and including, 4.15.18 via the WordPress core search feature. This makes it possible for unauthenticated attackers to extract sensitive data from posts that have been restricted to higher-level roles such as administrator.

Patch / fix

  • profilepress profilepress 4.15.19
  • profilepress user_registration,_login_form,_user_profile_&_membership 4.15.19
  • properfraction profilepress 4.15.19

Is CVE-2024-11083 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
none
Automatable
yes
Technical impact
partial
Assessed
last yr.

Exploit prediction

0.44% chance of exploitation in the next 30 days, higher than 39% of all scored CVEs (FIRST EPSS, 2026-11-20).

CVSS scores

assigned by version score vector
CNA 3.1 5.3 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Affected products

  • properfraction Paid Membership Plugin, Ecommerce, User Registration Form, Login Form, User Profile & Restrict Content – ProfilePress
  • profilepress loginwp

Classification

Weakness
  • CWE-200 Exposure of Sensitive Information to an Unauthorized Actor
Technology feeds

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.